CDIOW

Cardio Diagnostics Holdings, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.02

-0.00 (-17.03%)

Rating:B

Company Profile

CEO

Meeshanthini V. Dogan

IPO Date

2022-01-14

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$0.02

Prev. Close

$0.02

Day Low

$0.02

Day High

$0.02

52W Low

$0.02

52W High

$0.02

Market Cap

$0.00B

Volume

0.00M

Price Chart

+16.15% over 1M

About

Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.

https://cardiodiagnosticsinc.com

Price Performance

1 Day

-17.03%

5 Days

-40.08%

1 Month

+15.27%

3 Months